Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Unique ligand binding patterns between estrogen receptor alpha and beta revealed by hydrogen-deuterium exchange.

Dai SY, Burris TP, Dodge JA, Montrose-Rafizadeh C, Wang Y, Pascal BD, Chalmers MJ, Griffin PR.

Biochemistry. 2009 Oct 13;48(40):9668-76. doi: 10.1021/bi901149t.

2.

A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding.

Gunther JR, Du Y, Rhoden E, Lewis I, Revennaugh B, Moore TW, Kim SH, Dingledine R, Fu H, Katzenellenbogen JA.

J Biomol Screen. 2009 Feb;14(2):181-93. doi: 10.1177/1087057108329349.

3.

Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.

Berrodin TJ, Chang KC, Komm BS, Freedman LP, Nagpal S.

Mol Endocrinol. 2009 Jan;23(1):74-85. doi: 10.1210/me.2008-0366.

PMID:
19036900
4.

Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor alpha selective activity.

Zhou HB, Carlson KE, Stossi F, Katzenellenbogen BS, Katzenellenbogen JA.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):108-10. doi: 10.1016/j.bmcl.2008.11.006.

5.
6.

Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.

Jeyakumar M, Webb P, Baxter JD, Scanlan TS, Katzenellenbogen JA.

Biochemistry. 2008 Jul 15;47(28):7465-76. doi: 10.1021/bi800393u.

7.

Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method.

Dai SY, Chalmers MJ, Bruning J, Bramlett KS, Osborne HE, Montrose-Rafizadeh C, Barr RJ, Wang Y, Wang M, Burris TP, Dodge JA, Griffin PR.

Proc Natl Acad Sci U S A. 2008 May 20;105(20):7171-6. doi: 10.1073/pnas.0710802105.

8.

Conjugated equine estrogen enhances rats' cognitive, anxiety, and social behavior.

Walf AA, Frye CA.

Neuroreport. 2008 May 7;19(7):789-92. doi: 10.1097/WNR.0b013e3282fe209c.

9.

Estrogen receptor beta: an overview and update.

Zhao C, Dahlman-Wright K, Gustafsson JA.

Nucl Recept Signal. 2008 Feb 1;6:e003. doi: 10.1621/nrs.06003. Review.

10.
11.

Estrogen receptors: how do they signal and what are their targets.

Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson JA.

Physiol Rev. 2007 Jul;87(3):905-31. Review.

12.

Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial.

Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Adamo EB, Wilson S, Squadrito F.

Ann Intern Med. 2007 Jun 19;146(12):839-47.

PMID:
17577003
13.

Hormonal therapy for prostate cancer.

Brawer MK.

Rev Urol. 2006;8 Suppl 2:S35-47.

14.

Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies.

Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW.

Menopause. 2006 Sep-Oct;13(5):831-9. Review.

PMID:
16932241
15.

Pharmacological options in resistent ovary syndrome and premature ovarian failure.

Check JH.

Clin Exp Obstet Gynecol. 2006;33(2):71-7. Review.

PMID:
16903240
16.

Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.

Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.

Biochem Pharmacol. 2006 May 14;71(10):1459-69.

PMID:
16554039
17.
18.
19.
20.

Estrogen receptor microarrays: subtype-selective ligand binding.

Kim SH, Tamrazi A, Carlson KE, Daniels JR, Lee IY, Katzenellenbogen JA.

J Am Chem Soc. 2004 Apr 21;126(15):4754-5.

PMID:
15080660
Items per page

Supplemental Content

Support Center